Search research articles
Contact Us
Filters
Showing results (11-20 of 132) with videos related to
Page
of 14
Sort By:
European Journal of Haematology
|
May 6, 2016
Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy
Mohammad Faizan Zahid, Mrinal M Patnaik, Naseema Gangat, et al.
Chest
|
August 11, 2004
Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?
Rajesh Bhagat, David A Rizzieri, James J Vredenburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2005
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia
Ryan H Shanks, David A Rizzieri, James L Flowers, et al.
Leukemia & Lymphoma
|
April 10, 2008
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
David J Adams, Marit L Sandvold, Finn Myhren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome
Angel Y F Kam, Sadhna O Piryani, Chad M McCall, et al.
Leukemia & Lymphoma
|
January 7, 2016
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
David A Rizzieri, Sarah Cooley, Olatoyosi Odenike, et al.
American Journal of Hematology
|
June 20, 2015
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy
Patrick T Griffin, Rami S Komrokji, Carlos M De Castro, et al.
Molecular Cancer Research : MCR
|
January 30, 2021
Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells
Angel Y F Kam, Sadhna O Piryani, Chang-Lung Lee, et al.
American Journal of Hematology
|
July 25, 2003
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series
Jeffrey Talbot, David A Rizzieri, Carlos M DeCastro, et al.
Leukemia & Lymphoma
|
December 17, 2025
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 132) with videos related to
Sort By:
Page
of 14
European Journal of Haematology
|
May 6, 2016
Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy
Mohammad Faizan Zahid, Mrinal M Patnaik, Naseema Gangat, et al.
Chest
|
August 11, 2004
Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?
Rajesh Bhagat, David A Rizzieri, James J Vredenburgh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2005
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia
Ryan H Shanks, David A Rizzieri, James L Flowers, et al.
Leukemia & Lymphoma
|
April 10, 2008
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
David J Adams, Marit L Sandvold, Finn Myhren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome
Angel Y F Kam, Sadhna O Piryani, Chad M McCall, et al.
Leukemia & Lymphoma
|
January 7, 2016
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
David A Rizzieri, Sarah Cooley, Olatoyosi Odenike, et al.
American Journal of Hematology
|
June 20, 2015
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy
Patrick T Griffin, Rami S Komrokji, Carlos M De Castro, et al.
Molecular Cancer Research : MCR
|
January 30, 2021
Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells
Angel Y F Kam, Sadhna O Piryani, Chang-Lung Lee, et al.
American Journal of Hematology
|
July 25, 2003
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series
Jeffrey Talbot, David A Rizzieri, Carlos M DeCastro, et al.
Leukemia & Lymphoma
|
December 17, 2025
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, et al.
Page
of 14